(Received for publication July 18, 1985) We investigated the effects of the immunoactive peptides, FK 156 and FK 565, on functions of mouse macrophages.
FK 156 and FK 565 given parenterally or orally to mice enhanced spreading of peritoneal macrophages, phagocytosis of latex particles and intracellular killing of bacteria by peritoneal macrophages.
FK 156 and FK 565 also enhanced the production of superoxide anion and lysosomal enzyme activities of macrophages. The peptides also activated mouse spleen macrophages, and the kinetics of this activation differed from that of the peritoneal macrophages.
In addition, both drugs directly enhanced the production of superoxide anion by mouse peritoneal macrophages treated in vitro and enhanced the functions of peritoneal macrophages of athymic nude mice. Both these phenomena suggest that direct activation might be one of the mechanisms of macrophage activation by the peptides.
We reported that FK 156, an immunoactive peptide, isolated from culture filtrates of Streptomyces olivaceogriseus sp. nov. and its synthetic analog, FK 565, afforded strong resistance to microbial infections in normal and immunosuppressed mice1,2), and enhanced the host defense mechanisms against infections3). These peptides also had various immunostimulating activities such as adjuvant effects on humoral and cellular immunity and mitogenic activity4).
Macrophages play an important role not only in host resistance to microorganisms and tumors5) but also in the regulation of immunity6). In this study, we investigated the effects of FK 156 and FK 565 on such functions of macrophages as the spreading on the substratum, phagocytosis, intracellular killing of bacteria, production of superoxide anion and lysosomal enzyme activities.
Materials and Methods

Animals
Four-week old male ICR strain mice and eight-week old male normal and nude Balb/c strain mice were purchased from Japan Clea Co., Ltd.
Immunostimulants FK 156 and FK 565 were prepared in the Research Laboratories of Fujisawa Pharmaceutical Co., Ltd. (Osaka, Japan). They were dissolved in saline and given to mice in a single intraperitoneal or subcutaneous dose of 1 mg/kg. FK 565 dissolved in 0.5 % methylcellulose was given in oral doses of 0.1 mg/kg 6, 5, 4 and 1 day before the experiment.
Preparation of Peritoneal and Spleen Macrophages
Mouse peritoneal cells were collected by the method of BJORNSON7) without induction. The purity of the resident macrophage preparation was more than 90%. The cells were washed and allowed to adhere to tissue culture dishes in DULBECCO'S modified EAGLE'S minimum essential medium (DMEM) containing 10% fetal bovine serum (FBS) for 2 hours. After washing twice with the medium, the adherent cells were assayed for spreading, production of superoxide anion (O2-) and lysosomal enzyme activities.
To obtain spleen macrophages, mouse spleens were dispersed to single cells and allowed to adhere to tissue culture dishes for 2 hours. The adherent cells collected with a rubber spatula were washed and assayed for the production of O2-.
Phagocytosis
Peritoneal macrophages (I 107 cells/ml) were mixed with latex particles (0.08%) in a siliconized test tube and incubated at 37°C for 1 hour with continuous shaking. Then, the macrophages were washed 3 times with saline, smeared on a glass slide, fixed and stained with Giemsa stain. Latex particles engulfed by 100 macrophages were randomly counted in microscopic fields.
Spreading
Peritoneal macrophages at the density of 5 x 104 cells/well in a 24 well-multiwell plate (Nunclon) were adhered by the above method and cultured in fresh medium for 4 more hours. The number of cells with pseudopods per 100 macrophages were counted in microscopic fields.
Intracellular Killing Intracellular killing activity of macrophages was assayed by the modified method of ZWET8). That is, 2 x 107viable Pseudomonas aeruginosa were inoculated into the peritoneal cavity of mice to be engulfed by peritoneal macrophages. After 3 minutes, the peritoneal macrophages were collected and washed to remove free bacteria. The macrophage preparations were incubated at 37°C for appropriate times and then disrupted with saline containing 0.1 % sodium dodecyl sulfate (SDS). The released viable bacteria were counted by the agar plating method to determine colony forming units.
Production of O2-Production of O2-by macrophages was measured as the reduction of ferricytochrome c by the method of JOHNSTON9) . Phorbol myristate acetate (Sigma Chemical Co.) was used as stimulant at a concentration of 4 pig/ml. For the peritoneal macrophages, the results were expressed as nanomoles of 02-released for 90 minutes per mg of adherent cell protein. The protein was determined by the method of LowRY10) after lysing the washed adherent macrophages with 0.05% triton X-100. For the spleen macrophages, the experiments were conducted in a suspension culture, and the results were expressed as nanomoles of O2-released per 107 cells for 90 minutes.
Assay of Lysosomal Enzymes
i-Glucuronidase was assayed by hydrolysis of phenolphthalein-,3-glucuronide at pH 4.511). Lysozyme was assayed by the turbidimetric method using Micrococcus lysodeikticus11). Intracellular enzyme activity was assayed after destruction of cells by 3 freeze-thaw cycles.
Results
Phagocytosis
Peritoneal macrophages from mice intraperitoneally injected with FK 156 engulfed 1.81 times more latex particles than those from the control mice injected with saline (Table 1) . Also, peritoneal macrophages from mice orally dosed with FK 565 engulfed 2.15 times more latex particles than the control macrophages.
Intracellular Killing
Relative viable counts of intracellular bacteria after incubation, compared with an initial one , were plotted against incubation time (Fig. 1) Table 2) .
Superoxide anion is one of the reactive oxygen intermediates which are produced by phagocytes when responding to such stimuli as phagocytosis of bacteria, and plays a major role in the killing of bacteria9,12). Fig. 2 and Table 3 show the production of O2-by mouse peritoneal and spleen macrophages. For peritoneal macrophages, FK 156 markedly enhanced the production of O2-up to 7 days after intraperitoneal or subcutaneous injection (Fig. 2a) . However, for spleen macrophages, FK 156 enhanced the production of O2-only I day after injection (Fig. 2b) . FK 565, given orally, also enhanced the production of O2- (Table 3 ). In addition, FK 156 and FK 565 enhanced the production of O2-by peritoneal macrophages treated in vitro (Fig. 3) .
Lysosomal Enzyme Activity
Among the biochemical aspects of the activities of activated macrophages, the intracellular level Peritoneal macrophages were obtained from mice 4 days after intraperitoneal injection with 1 mg/kg of FK 156 or 1 day after 4 oral dosings with 0.1 mg/kg of FK 565. (Fig. 4b) .
Involvement of T Cells in Macrophage Activation by FK 156
The production of O2-and phagocytosis of latex particles by peritoneal macrophages from athymic nude mice injected with FK 156 and FK 565 were studied to determine the invohvement by FK 156 and FK 565 could be related to the enhanced production of O2-. COHN claimed that there were two steps in macrophage activation, a nonspecific inflammatory event and a lymphokinemediated event, and the macrophages in the latter event expressed microbicidal and tumoricidal activities 17). Since FK 156 and FK 565 enhanced host resistance to various infections by facultative intracellular and extracellular bacteria1,2)I, and their enhancing effects were consistent with the in vitro findings, it is suggested that the peptides themselves activated macrophages and this activation was not merely the effect of inflammation. Fig. 2 shows the different time courses of activation between peritoneal and spleen macrophages by FK 156, and the results for spleen macrophages are consistent with those for the reticuloendothelial system measured by carbon clearance3). These findings are of interest because they suggest that the activation of free and fixed macrophages by FK 156 might be induced by different mechanisms.
Although we could not fully elucidate the mechanism of macrophage activation by these peptides, direct activation might be one of the mechanisms of their action judging from the results presented in Fig. 3 . However, indirect activation via lymphocytes or soluble factors is also a possibility since the activation by FK 156 was relatively slow in vivo (see Fig. 2a ) compared with muramyldipeptide (MDP) which was reported to enhance the production of O2-by peritoneal macrophages a few hours after injection18,19). Our findings that FK 156 and FK 565 induced interferon (data not shown) and the observations of GOTOH et al. that FK 156 had mitogenic and adjuvant activities') support this indirect activation.
It is no doubt that macrophage activation by the immunoactive peptides relates to the enhancement of nonspecific resistance to infection. In addition, this macrophage activation might play a role in other immunological responses such as adjuvant activity, because it is well known that macrophages regulate the immune responses via antigen presentation or enhancement of T cell function. Additionally, it is reported that in studies on MDP derivatives, there was a correlation between macrophage activation and adjuvant activity20). Therefore, macrophage activation might have an important role in the expression of various biological activities of FK 156 and FK 565.
